Valneva SE VALN
NASDAQ VALN
$6.91 -0.15 (-2.20%)
As of: Sep 4, 2026 · 3:14 PM EDT

Valneva SE (VALN) EBT (2021 - 2026)

Valneva SE (VALN) posted EBT of -$36.6 million for Q1 2026, up 38.47% sequentially from -$59.5 million in Q4 2025, and down 348.31% YoY from $14.7 million in Q1 2025.

Analysis

Valneva SE (VALN) EBT (2021 - 2026) Analysis & Trends

Valneva SE has reported EBT for 6 years, with the latest figure at -$36.6 million in Q1 2026.

  • Quarterly EBT fell 348.31% year-over-year to -$36.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$160.2 million (down 90.79% YoY) and the FY2025 annual result came in at -$132.8 million, down 968.55% from the prior year.
  • EBT rose to -$36.6 million in Q1 2026 per VALN's latest filing, from -$59.5 million in the prior quarter.
  • Over five years, EBT peaked at $72.9 million in Q3 2022 and troughed at -$153.3 million in Q2 2022.
  • A 5-year average of -$26.2 million and a median of -$28.7 million in 2022 frame the typical range for EBT.
  • The sharpest annual moves came in 2024 and 2026: EBT surged 426.81% in 2024, then plunged 348.31% in 2026.
  • Over 5 years, EBT stood at -$48.9 million in 2022, then soared by 37.8% to -$30.4 million in 2023, then dropped by 13.7% to -$34.6 million in 2024, then tumbled by 72.01% to -$59.5 million in 2025, then jumped by 38.47% to -$36.6 million in 2026.
  • According to Business Quant data, EBT over the past three periods registered -$36.6 million, -$59.5 million, and -$50.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 1.39 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 1.53 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn 542.00 Mn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn -767.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn - -644.37 Mn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 312.46 Mn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 177.81 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn - 81.49 Mn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -11.37 Mn
10 Valneva SE 580.64 Mn 439.38 Mn 1.86 Mn -36.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -36.93 Mn
Mar 31, 2026 -36.58 Mn
Dec 31, 2025 -59.46 Mn
Sep 30, 2025 -50.82 Mn
Jun 30, 2025 -13.37 Mn
Mar 31, 2025 -8.16 Mn
Dec 31, 2024 -34.57 Mn
Sep 30, 2024 -14.23 Mn
Jun 30, 2024 -27.03 Mn
Mar 31, 2024 64.01 Mn
Dec 31, 2023 -30.40 Mn
Sep 30, 2023 -34.35 Mn
Jun 30, 2023 -22.41 Mn
Mar 31, 2023 -19.59 Mn
Dec 31, 2022 -48.87 Mn
Sep 30, 2022 72.91 Mn
Jun 30, 2022 -153.32 Mn
Mar 31, 2022 -28.66 Mn
Dec 31, 2021 199.40 Mn
Sep 30, 2021 -186.98 Mn